Evidence-Based Medicine Guidelines
Bromocriptine/levodopa combined vs. levodopa alone for early Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bromocriptine/levodopa Combined Vs. Levodopa Alone for Early Parkinson's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451775/all/Bromocriptine_levodopa_combined_vs__levodopa_alone_for_early_Parkinson's_disease.
Bromocriptine/levodopa combined vs. levodopa alone for early Parkinson's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451775/all/Bromocriptine_levodopa_combined_vs__levodopa_alone_for_early_Parkinson's_disease. Accessed October 13, 2024.
Bromocriptine/levodopa combined vs. levodopa alone for early Parkinson's disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451775/all/Bromocriptine_levodopa_combined_vs__levodopa_alone_for_early_Parkinson's_disease
Bromocriptine/levodopa Combined Vs. Levodopa Alone for Early Parkinson's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451775/all/Bromocriptine_levodopa_combined_vs__levodopa_alone_for_early_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bromocriptine/levodopa combined vs. levodopa alone for early Parkinson's disease
ID - 451775
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451775/all/Bromocriptine_levodopa_combined_vs__levodopa_alone_for_early_Parkinson's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
